T. Rowe Price Investment Management, Inc. 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:28 pm Purchase |
2024-09-30 | 13G | Immunocore Holdings plc IMCR |
T. Rowe Price Investment Management, Inc. | 6,499,835 13.000% |
1,334,936 (+25.85%) |
Filing |
| 2024-09-10 1:49 pm Purchase |
2024-08-31 | 13G | Immunocore Holdings plc IMCR |
T. Rowe Price Investment Management, Inc. | 5,164,899 10.300% |
5,164,899 (New Position) |
Filing |